Skip to main content

Cardenolide

ADVERTISEMENT
Identification
Molecular formula
C23H34O3
CAS number
508-52-1
IUPAC name
5-[(10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-1,2,7,8,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
State
State

At room temperature, cardenolides are typically in a solid state. They can be crystalline and are often used in the form of powders for research and medicinal purposes.

Melting point (Celsius)
250.00
Melting point (Kelvin)
523.15
Boiling point (Celsius)
650.00
Boiling point (Kelvin)
923.15
General information
Molecular weight
374.46g/mol
Molar mass
374.4610g/mol
Density
1.2600g/cm3
Appearence

Cardenolides are typically crystalline solid compounds. They may appear as white or off-white crystals or powders, depending on the specific cardenolide compound and its purity level.

Comment on solubility

Solubility of 5-[(10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-1,2,7,8,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one

The solubility of the compound 5-[(10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-1,2,7,8,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one can be influenced by several factors such as polarity, temperature, and the presence of solvents. Understanding the solubility characteristics is vital for applications in pharmaceuticals and materials science.

Factors Influencing Solubility

  • Polarity: The structure of the compound suggests a significant presence of hydroxy groups which can lead to increased polarity, potentially enhancing solubility in polar solvents like water.
  • Molecular Interactions: Hydrogen bonding and Van der Waals forces play critical roles in solubility; products able to form hydrogen bonds with solvent molecules generally exhibit better solubility.
  • Temperature: Typically, an increase in temperature may increase solubility for most solids, allowing for a greater dissolution rate in solution.

It is important to note, however, that due to the complex nature of this compound, solubility testing in various solvents would provide more specified insights and aid in crystallization and formulation processes. As the saying goes, "The key to effective solutions is understanding solubility."

Interesting facts

Interesting Facts about 5-[(10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-1,2,7,8,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one

This compound is a fascinating example of a complex organic molecule with significant implications in various fields, particularly in medicinal chemistry.

Key Characteristics

  • Structural Complexity: The compound features multiple chiral centers, indicating that it can exist in different stereoisomer forms. This structural diversity allows for various biological activities and interactions.
  • Potential Biological Activity: The presence of hydroxy groups and distinct cyclic structures suggests that this compound might possess interesting pharmacological properties, potentially acting as a scaffold for drug development.
  • Natural Sources: Compounds similar to this one are often derived from natural products, which are known to inspire new pharmaceutical agents due to their inherent biological significance.

Applications in Research

Given its unique structure, researchers may explore the compound for:

  • Novel therapeutic properties in treating diseases.
  • Drug design, as a model to understand mechanisms of action.
  • Studying its interactions with biological macromolecules like proteins or nucleic acids.

Quote to Reflect On

"Chemistry is the study of change." – Walter White

This quote highlights the transformative potential of compounds such as this one in the realm of chemistry and health sciences.

Conclusion

The compound's intricate design not only showcases the beauty of organic chemistry but also sparks curiosity about its possible applications in the medical field. With ongoing research, compounds like this hold the promise of unlocking new pathways for therapeutic advancements.

Synonyms
Scillaridin A
545-51-7
5-[(10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-1,2,7,8,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
BRN 0047346
Scillaridine
14-Hydroxy-bufa-3,5,20,22-tetraenolide
Bufogenatetraen-(3,5,20,22)-olid [German]
14-Oxy-bufotetraen-(3,5,20,22)-olid [German]
14-Oxy-scilltetraen-(3,5,20,22)-olid [German]
Bufogenatetraen-(3,5,20,22)-olid
14-Oxy-bufotetraen-(3,5,20,22)-olid
14-Oxy-scilltetraen-(3,5,20,22)-olid
4-18-00-00682 (Beilstein Handbook Reference)
BUFA-3,5,20,22-TETRAENOLIDE, 14-HYDROXY-
DTXSID00969683
FS61655
14-Hydroxybufa-3,5,20,22-tetraenolide
14beta-Hydroxybufa-3,5,20,22-tetraenolide